{
    "2020-07-07": [
        [
            {
                "time": "2021-07-15",
                "original_text": "Johnson & Johnson (JNJ) Stock Moves -0.09%: What You Should Know",
                "features": {
                    "keywords": [
                        "Johnson & Johnson",
                        "Stock Moves",
                        "-0.09%"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-07-15",
                "original_text": "Emergent's (EBS) 5-Year Deal to Back J&J's Coronavirus Vaccine",
                "features": {
                    "keywords": [
                        "Emergent",
                        "5-Year Deal",
                        "J&J",
                        "Coronavirus Vaccine"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2021-07-15",
                "original_text": "U.S. government awards Novavax $1.6 billion for coronavirus vaccine",
                "features": {
                    "keywords": [
                        "U.S. government",
                        "Novavax",
                        "$1.6 billion",
                        "coronavirus vaccine"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}